36 Medidata Solutions Testimonials

"Major corporations such as pharmaceutical and medical device manufacturers and institutions such as hospitals and nursing facilities have also committed fraud, sometimes on a grand scale. OIG has a strong record of investigating these corporate and institutional frauds, which often involve complex billing frauds, kickbacks, accounting schemes, illegal marketing and physician self-referral arrangements."

"The Medidata products are very innovative and support our very complex oncology studies."

"We needed to find a trusted partner to work with us, to grow with us AND deliver and provide innovative technology solutions for our clinical trials, we found that partner in Medidata."

“It is to everyone’s advantage to [use Medidata’s] unified platform so that there is one login. There is one way that people are accessing all the things they need to do with their data. If we’re thinking of patients and sites first, we have to think about that value…[so] they’re not worried about having multiple laptops and multiple logins.”

“Our partnership with Medidata has enabled us to offer top-notch service to sponsors. In the last decade, we’ve embraced the latest Rave EDC technology, including eCOA/ePRO via the Patient Cloud and Rave Coder. We’ve successfully configured intricate study designs, from early-phase oncology with numerous protocol changes to rare disease studies with diverse data collection methods.”

“One of the things that attracted me to Medidata was their ability to have a support mechanism [beyond] internal experts. Having a broad reach across the globe and supporting end users with devices are important. These factors attracted me to the Medidata DCT Program because not all competitors have that reach with their help desk and device support. It’s nice to have a reputable organization that allows us to lean on."

"Since Medidata developed the web services on the open operational data model (ODM) standard, Spaulding can rapidly apply integration designs to other studies and sponsors."

"Medidata operational support has made us more efficient by enabling us to reallocate resources to focus on what's most important - clinical research."

"We want to use the best in-class technology and we want to combine that with our clinical research."

“We don’t compromise on quality, and we are always innovating and striving for improvement. In Medidata, we have found a technology partner that does the same. Medidata is renowned as one of the best companies in terms of technological solutions for clinical trials.”

"When compared with traditional cardiovascular trials that engage hundreds or thousands of sites, this technology allowed us to enroll 15,000 participants from 40 centers. We think this infrastructure and approach will facilitate studies that can be direct-to-patient, easier for patients and investigators, and faster to completion."

"Our partnership with Medidata has been very collaborative from a data management perspective in rolling out all the new applications and tools and integrating them with EDC. It’s made data management easier for reviewing the data, drawing out metrics, and building the forms. It’s an easier platform to design and then work with integrating new tools like RTSM or eCOA/ePRO.”

"We eliminated double data entry at the medical institution and were able to improve efficiency in clinical trial data capture."

“The partnership with Medidata further underscores TissueTech’s commitment to evidence-based medicine, scientific integrity and continuous research and innovation. Medidata’s unified platform provides us with the technology foundation to scale our clinical research, address the complexity of today’s clinical trials, and build and maintain efficiencies as we continue to grow.”

"We didn’t go shopping, we knew we wanted to use Medidata and it was a matter of working to find the right study build model to fit our business needs.”